ABBISKO-B (02256) announced that its board has been informed by Dr. Xu Yaochang, the company's founder, executive director, chief executive officer, and board chairman, of his purchase of 45,000 ordinary shares in the company on March 3, 2026. The shares were acquired on the open market at an average price of approximately HK$11.26 per share, representing about 0.01% of the company's total issued share capital. Following this transaction, Dr. Xu holds an interest in a total of 81,769,968 shares, accounting for approximately 12.02% of the company's total issued shares as of the date of this announcement. According to Dr. Xu, he maintains strong confidence in the business prospects and growth potential of the group. Subject to compliance with applicable laws and regulatory requirements, Dr. Xu does not rule out the possibility of further increasing his stake in the company at an appropriate time.